London, UK (PRWEB) June 24, 2014
At present, China is one of the biggest pharmaceuticals markets across the globe. Still, the country’s market is not yet mature and is considered to have a huge growth potential, supported by the ongoing economic development, rapidly increasing population, as well as growing healthcare awareness. The combination of such factors as government stimulus packages, demographic development, market consolidation, enhanced health awareness among the country’s population, and also improving R&D performance drives China to grow into a more sophisticated market for pharmaceuticals during the next 10 years.
During the last decade, the demand for allergy drugs in China grew at a rapid pace. Furthermore, both the production of, and demand for allergy drugs in the country are poised to follow an upward trend in the next five years.
New research report “Allergy Drugs Market Research (China)” drawn up by Asia Market Information & Development Co (AMID) is available at MarketPublishers.com.
Title: Allergy Drugs Market Research (China)
Published: June, 2014
Price: US$ 4,000.00
A holistic view of the Chinese allergy drugs market scenario along with an insightful review of the historical development of the sector is provided in the new report. The research report offers a close look at the market dynamics, contains accurate statistics on the local allergy drugs production and demand, describes the business environment in China and also touches upon the regulative issues. The study includes a detailed industry structure analysis, reviews the major factors influencing the market development and gives insights into the competitive climate in the Chinese allergy drugs market. Besides, the study provides a pack of the valuable industry performance statistics, as well as provides forecasting of the Chinese allergy drugs market performance through 2018 and to 2023-end.
More new market research reports by the publisher can be found at AMID page.